Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2024-07-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan
Share Issue/Capital Change Classification · 100% confidence The document details the reclassification of class C shares into ordinary shares and the subsequent transfer of those shares to participants of a long-term incentive plan (LTIP). This involves changes to the company's capital structure and the issuance/transfer of shares. According to the filing definitions, announcements regarding new share issues, stock splits, or other capital changes fall under the 'SHA' category.
2024-07-31 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Biotage AB covering the period January to June 2024. It contains comprehensive financial statements, including income statements, cash flow data, and management commentary on performance, which aligns with the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report, as it contains the full financial data and analysis. H1 2024
2024-07-16 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report January - June 2024' for Biotage AB. It contains comprehensive financial statements, including net sales, EBITDA, operating profit, and cash flow data for the quarter and six-month period. It also includes a 'Message from the CEO' and detailed financial analysis, which is characteristic of an interim financial report rather than a simple earnings release or announcement. H1 2024
2024-07-16 English
Beslut vid årsstämma i Biotage AB den 25 april 2024
AGM Information Classification · 99% confidence The document is titled "Beslut vid årsstämma i Biotage AB den 25 april 2024" (Decisions at the Annual General Meeting in Biotage AB on April 25, 2024). It details specific resolutions passed at the meeting, including decisions on dividend distribution, granting discharge to the board, election of board members and auditors, setting board remuneration, approving guidelines for executive compensation, and approving a new incentive program (LTIP 2024). These topics are central to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the classification is AGM-R (AGM Information). The document is the official record of the decisions made, not just an announcement of a future meeting or a proxy statement.
2024-04-25 Swedish
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2024
AGM Information Classification · 99% confidence The document title explicitly states 'Resolutions at the Annual General Meeting in Biotage AB on April 25, 2024'. The content details specific resolutions passed regarding dividend appropriation, board member elections, auditor appointments, remuneration, and the adoption of a Long-Term Incentive Plan (LTIP). These are the typical outcomes and resolutions announced following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information). The document is not a proxy statement (PSI) or a general earnings release (ER), but a summary of the meeting's decisions.
2024-04-25 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Biotage AB covering the period January to March 2024. It contains detailed financial statements, including income statements, cash flow analysis, and management commentary on performance, which fits the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report, as it contains the full financial data and analysis. Q1 2024
2024-04-25 Swedish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.